NOSIKIND P 2% W/V/0.05% W/V NASAL DPS

Overview

NOSIKIND P 2% W/V/0.05% W/V NASAL DPS is a Schedule H drug.

NOSIKIND P 2% W/V/0.05% W/V NASAL DPS is composed of: SORBITOL (2.0 %W/V), XYLOMETAZOLINE (0.05 %W/V)

Sorbitol is a hyperosmotic laxative used to treat occasional constipation.

Xylometazoline nasal is a decongestant that shrinks blood vessels in the nasal passages. Dilated blood vessels can cause nasal congestion (stuffy nose). Xylometazoline nasal (for use in the nose) is used to treat stuffy nose caused by allergies, sinus irritation, or the common cold. Ophthalmic- Relieving redness in eyes. 

Usage

SORBITOL is generally used to treat: Constipation

XYLOMETAZOLINE is generally used to treat: Sinus Infection, Common Cold

Frequently Asked Questions

Q: Is it safe on my liver?
A: Not Safe

Q: Is it safe on my kidney?
A: Check with your Doctor first

Q: Can I take it with alcohol?
A: Not Safe

Q: Is it safe for children?
A: Not Advised for age < 2yrs

Q: Is it safe to take for someone breastfeeding?
A: Check with your Doctor first

Precautions for NOSIKIND P 2% W/V/0.05% W/V NASAL DPS and its Constituents

Caution should be exercised in patients with history of hypersensitivity, diabetes, abdominal pain, nausea, vomiting, rectal bleeding, a sudden change in bowel habits lasting over 2 weeks, elderly, children, pregnant and breastfeeding women. Do not take additional laxatives or stool softeners while taking this medication unless directed by your doctor. Do not use this medication beyond the recommended dose. This medication should be used only by the patient for whom it is prescribed. Do not share it with others. Do not use this medication for longer than 1 week without consulting with your health care provider.
Caution needed for young children, during pregnancy and lactation, patients with history of high blood pressure, cardiovascular abnormalities, diabetes mellitus, hyperthyroidism, and difficulty in urination secondary to prostate enlargement. To prevent the spread of infection; do not share this medication with others. Do not use this nasal preparation for longer than 3 to 5 days. Rebound congestion may occur after prolonged regular use. Avoid prolonged usage.

Symptoms of Overdosage

SORBITOL over-dosage can result in: Abdomen Stomach Cramps
XYLOMETAZOLINE over-dosage can result in: Drowsiness, Slow Heart Rate (pulse), Dizziness, Fainting

Common Side-Effects

SORBITOL : Diarrhoea, Nausea, Skin Irritation
XYLOMETAZOLINE : Runny Nose, Sneezing

Serious Side-Effects

SORBITOL : Vomit, Weakness (generalized), Dizziness
XYLOMETAZOLINE : Nausea, Head Headache, Mood Swings, Difficulty Sleeping, Fatigue (tiredness), Body Excessive Sweating

Rare Side-Effects

SORBITOL : Skin Rash, Face Swelling, Body Itching, Difficulty Breathing
XYLOMETAZOLINE : Skin Rash, Difficulty Breathing, Face Swelling, Body Itching

Disease Interactions

XYLOMETAZOLINE can interfere with: Benign Prostatic Hyperplasia, Prostate Cancer, Cerebrovascular Insufficeincy, Hyperthyroidism, Diabetes Mellitus

Technical Classification

SORBITOL is categorized as: LAXATIVES / GASTROINTESTINAL AGENTS
XYLOMETAZOLINE is categorized as: NASAL ANTIHISTAMINES AND DECONGESTANTS / NASAL PREPARATIONS / TOPICAL AGENTS

Available Alternatives for NOSIKIND P 2% W/V/0.05% W/V NASAL DPS

What are the commonly available Substitutes?

NOSIKIND P 2% W/V/0.05% W/V NASAL DPS

INR 32.67 for 10 ML NASAL DROPS

SORBITOL 2.0 %W/V, XYLOMETAZOLINE 0.05 %W/V

What are the other drugs with similar Ingredients?

COZYMIN 2% W/V/0.1% W/V NASAL SPRAY	INR 51.86 for 10 ML NASAL SPRAY	SORBITOL 2.0 %W/V, XYLOMETAZOLINE 0.1 %W/V
NOSIKIND 0.1% (NF) NASAL DPS	INR 50.61 for 10 ML NASAL DROPS	SORBITOL 2.0 %W/V, XYLOMETAZOLINE 0.1 %W/V
OTRINOZ N-DPS	INR 85 for 10 ML DROP	SORBITOL 2 %W/V, XYLOMETAZOLINE 0.1 %W/V
OTRINOZ PEDIATRIC NASAL DPS	INR 69 for 10 ML DROP	SORBITOL 0.2 %W/V, XYLOMETAZOLINE 0.1 %W/V